|
Rectum Cancer Cases
Case 1: Rectum cancer
Name: Luis Peralta
Age: 61 years old
Country: Uruguay
Reason of consultation:
01/09/2002 He consults because of vegetant tumoration
in lower rectum.
Personal antecedents:
No personal antecedents to remark.
Family antecedents:
None to remark.
Present disease antecedents:
Diarrheic depositions since a year ago with comes and
goes. Since 12/30/2001 presents recto-rraghia. He has
a PAI done and does not present any lesion. In a rectum
tactum it is detected tumoration in back and lateral
side of rectum, movable, of 30 mm approximately. The
CCV shows vegetant tumoration of lower rectum that infiltrates
circumferentially the wall 10 cm. Away from the anus
limit. The anatomy pathology result is expected.
On 01/09/2002 begins with the medicament at the dosage
of 40 drops 4 times per day sublingually.
Disease evolution:
02/01/2002: Presents well differentiated adeno-carcinoma,
infiltrative, of lower rectum. A front low resection
is performed plus TCT plus Chemotherapy. A relative
of his comes with data and clinical register, we indicate
increase the medicament dosage to 50 drops 4 times per
day sublingually.
07/24/2002: The patient comes to consult in good general
state. He presents surgery scar without particularities.
The abdomen is soft, depressible and painless, no viscero-megalies
are palpable. He finished with concomitant radiotherapy
and chemotherapy. Intestinal transit conserved. Professor
Torres will see him in a month time. 30 drops 4 times
per day are recommended. A control is requested in a
month and a half time. Hyperproteic diet.
08/14/2002: The patient comes to consult and is stable,
in hospital oncology control. He goes on with 30 drops
4 times per day sublingually.
At the present moment, in clinic cure, on release, with
a maintenance dosage of the medicament.
Conclusions:
It is about a patient of 61 years
old proceeding from Uruguay, with an infiltrative well
differentiated lower rectum adeno-carcinoma, he underwent
a low front resection plus telecobalto-therapy plus
chemotherapy.
On 01/09/2002: begins with the medicament at a dosage
of 40 drops, 4 times per day sublingually, which afterwards
is increased to 50 drops 4 times per day.
He achieves total improvement and we can see GREEN SAP
action in a well differentiated lower rectum adeno-carcinoma.
With no doubt GREEN SAP with its action contributed
to the no appearance of metastases and the clinic cure
of the patient, who also was treated with conventional
therapy, what shows GREEN SAP innocuousness, the high
tolerance to it and the lack of collateral effects which
led to the patient’s clinic cure. Remarking it
is not a clinic cure up to 5 years from now on, as we
stated at the beginning of this work, but the expression
of the excellent state of health that the patient has
at the present moment.
In this patient GREEN SAP action is of no doubt. The
experience we have indicates us that in his pathology,
is a medicament of first level, achieving complete remissions
and a life status, so important in these patients, very
superior, reason why there is no doubt for us that GREEN
SAP has achieved to revert and control the oncology
disease avoiding the dissemination as this work team’s
experience throughout the years we worked with this
medicament has seen
|
